These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28091698)

  • 1. [Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].
    Wohlrab J; Neubert RH; Sommer E; Michael J
    Hautarzt; 2017 Apr; 68(4):307-315. PubMed ID: 28091698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis.
    Clin Ther; 1985; 8(1):41-8. PubMed ID: 2870809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
    Jue SG; Dawson GW; Brogden RN
    Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical antifungal bigels: Formulation, characterization and evaluation.
    Mazurkeviciute A; Ramanauskiene K; Ivaskiene M; Grigonis A; Briedis V
    Acta Pharm; 2018 Jun; 68(2):223-233. PubMed ID: 29702483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
    Bogaert H; Cordero C; Ollague W; Savin RC; Shalita AR; Zaias N
    J Int Med Res; 1986; 14(4):210-6. PubMed ID: 3530834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses.
    Lassus A; Nolting KS; Savopoulos C
    Clin Ther; 1988; 10(5):594-9. PubMed ID: 2856602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclopirox for the treatment of superficial fungal infections: a review.
    Gupta AK; Skinner AR
    Int J Dermatol; 2003 Sep; 42 Suppl 1():3-9. PubMed ID: 12895181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urea treatment of mycoses].
    Nolting S
    Hautarzt; 1989; 40 Suppl 9():76-7. PubMed ID: 2807930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ciclopirox (Mycosten), topically].
    J Pharm Belg; 2013 Sep; (3):47-8. PubMed ID: 24804412
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of Ciclopirox Olamine after Buccal Administration in Rabbits.
    Lukášová I; Muselík J; Vetchý D; Gajdziok J; Gajdošová M; Juřica J; Knotek Z; Hauptman K; Jekl V
    Curr Drug Deliv; 2017; 14(1):99-108. PubMed ID: 27138296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of dermatoses : Significance and use of glucocorticoids in fixed combination with antifungals].
    Mayser P
    Hautarzt; 2016 Sep; 67(9):732-8. PubMed ID: 27411685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern methods in the treatment of the smooth skin mycoses].
    Glad'ko VV; Ustinov MV; Vorob'ev AB
    Voen Med Zh; 2007 Jul; 328(7):20-3. PubMed ID: 17902340
    [No Abstract]   [Full Text] [Related]  

  • 15. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.
    Greenberg HL; Shwayder TA; Bieszk N; Fivenson DP
    Pediatr Dermatol; 2002; 19(1):78-81. PubMed ID: 11860579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase III study of the efficacy and safety of ciclopirox olamine cream in small children with dermatomycosis].
    Gómez-Moyano E; Hiraldo Gamero A; Vera Casaño Á; Crespo Erchiga V; González Enseñat MA; Vicente Villa MA; Zsolt Fradera I; Moreno Giménez JC
    Rev Iberoam Micol; 2015; 32(3):164-9. PubMed ID: 25728876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclopirox (Loprox) gel for superficial fungal infections.
    Gupta AK; Bluhm R
    Skin Therapy Lett; 2004; 9(7):4-5, 9. PubMed ID: 15334276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
    Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
    J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis from ciclopirox olamine.
    Foti C; Diaferio A; Bonamonte D
    Australas J Dermatol; 2001 May; 42(2):145. PubMed ID: 11309043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.